Paula Abola | Neuroscience & Education | Neuroscience Academic Distinction Award

Mrs. Paula Abola | Neuroscience & Education | Neuroscience Academic Distinction Award

Mrs. Paula Abola | University of Jamestown | United States

Paula Abola is a clinical researcher and academic with a strong focus on Parkinson’s disease, clinical drug development, and chemical biology. She has earned advanced degrees in Clinical Research, Clinical Drug Development, and Medicinal Chemistry & Chemical Biology, completing dissertations that explored knowledge disparities and shared decision-making in Parkinson’s disease, as well as comparative efficacy studies of pharmacological interventions and novel synthetic approaches in chemical biology. Paula has extensive experience in higher education, serving as an adjunct professor at multiple international universities, where she designs and delivers graduate- and doctorate-level courses in systematic reviews, meta-analyses, survey research, research proposal writing, study design, statistical methods, and chemical biology, while also mentoring and supervising student research projects. Her work emphasizes bridging methodological rigor with practical applications in clinical and social research, including applications in pharmacological management and vaccine development. Paula’s research contributions are documented in 2 scholarly works, which have collectively received 2 citations, giving her an h-index of 1 and an i10-index of 0. Her academic and research endeavors reflect a dedication to advancing knowledge in clinical pharmacology, research methodology, and chemical biology while fostering the development of future researchers through mentorship and teaching.

Profiles: Google Scholar | Orcid | Research Gate | Linked In

Featured Publications

Abola, P., Lefebvre, K., & Wolden, M. (2025). Influence of sociodemographic variables on patient and practitioner knowledge of pharmacological management options for Parkinson’s disease. American Journal of Medical and Clinical Research & Reviews, 4(1), 1–16.

Abola, P., Wolden, M. (2024). Monoamine oxidase-B inhibitor rasagiline effects on motor and non-motor symptoms in individuals with Parkinson’s disease: A systematic review and meta-analysis. Advances in Parkinson’s Disease, 13(3), 27–56.

Abola, P., & Jabishvili, G. (2025). Incidence of adverse and safety events in individuals with Parkinson’s disease treated with catechol-O-methyltransferase inhibitor opicapone as an add-on to levodopa treatment. Prospects in Pharmaceutical Sciences.

Abola, P., & Lefebvre, K. (2025). Technological advancements in the reduction of Parkinsonian tremor: A scoping review. Topics in Geriatric Rehabilitation, 41(3), 162–170.

Abola, P., Wolden, B., & Wolden, M. (2025). Journal of Neurology & Neuropsychiatry. Neuropsychiatry, 2(1).

Abola, P., & Lefebvre, K. (2025). Technological advancements in the detection and quantification of Parkinsonian tremor: A scoping review. Topics in Geriatric Rehabilitation, 41(3), 154–161.

Abola, P., & Wolden, M. (2025). Intra-individual variations in voice variables among individuals with and without Parkinson’s disease. Cureus, 17(3).

Abola, P., & Lefebvre, K. M. (2025). Technological advancements in the rehabilitation of Parkinsonian tremor: A systematic review. 2025 Combined Sections Meeting (CSM).

Michael Leoncio | Neuroscience & Education | Best Researcher Award

Dr. Michael Leoncio | Neuroscience & Education | Best Researcher Award

Dr. Michael Leoncio, NIcklaus Childrne’s Hospital, United States.

Dr. Michael Leoncio is a dedicated pediatric critical care physician whose academic and professional journey reflects a deep passion for child health. Beginning with a dual degree in Chemistry and Physical Therapy, he went on to earn his D.O. from the New York College of Osteopathic Medicine. His clinical training took him from a pediatric residency in New Jersey to specialized fellowships at Miami Children’s Hospital, focusing on both general and cardiac pediatric critical care. Throughout his career, Dr. Leoncio has made significant contributions in the high-intensity environment of pediatric ICUs, shaping protocols, mentoring new clinicians, and improving outcomes for countless children.

Profile

Orcid

🎓 Early Academic Pursuits

Born in Hialeah, Florida, Dr. Michael Leoncio’s educational journey began with a strong dual foundation in Chemistry and Physical Therapy at the University of Miami, where he earned both his BHS and BA degrees. Driven by a passion for healing and science, he advanced to the New York College of Osteopathic Medicine, obtaining his Doctor of Osteopathy (D.O.) in 2004. These formative years were marked by his unwavering dedication to medicine and a growing interest in pediatric health, setting the stage for his future specialization in pediatric critical care.

🏥 Professional Endeavors

Following medical school, Dr. Leoncio completed a pediatric internship and residency at Newark Beth Israel Medical Center in New Jersey. His experiences under the mentorship of Dr. Josh Rosenblatt solidified his commitment to caring for children facing complex health challenges. He then pursued advanced fellowship training in Pediatric Critical Care Medicine from July 2007 to June 2010 at Miami Children’s Hospital, under Dr. Balaganghadar Totapally. Continuing his pursuit of excellence, he further specialized with an additional year as a Clinical Fellow in Pediatric Cardiac Critical Care Medicine, guided by Dr. Anthony Rossi. These rigorous training years provided Dr. Leoncio with extensive hands-on experience in managing critically ill children with cardiac conditions.

🔬 Contributions and Research Focus

Dr. Leoncio’s fellowship years were not only defined by clinical mastery but also by his engagement in cutting-edge pediatric and cardiac intensive care research. Working within high-acuity settings, he contributed to innovations in the care of neonates and children requiring intensive monitoring and support. His clinical insights have contributed to protocol advancements in cardiac intensive care, especially in the nuanced management of post-operative pediatric patients.

🏅 Accolades and Recognition

Throughout his academic and professional career, Dr. Leoncio has garnered recognition for his commitment to compassionate, evidence-based care. His peers and mentors have consistently praised his diligence, leadership qualities, and dedication to the field of pediatric critical care. These commendations reflect not only his technical expertise but also his empathetic approach to both patients and their families during the most vulnerable times.

Publication

  • Prevalence of Arginine Vasopressin Deficiency among Children and Adolescents Declared Dead by Neurologic Criteria
    Cesar Esteban Larancuent; Valandrea Merilan; Michael Leoncio; Juan Manuel Lozano; Balagangadhar R. Totapally | 2025

 

  • Epidemiology and outcomes of children with accidental hypothermia: A propensity-matched study
    Totapally A; Leoncio M; Beltramo F; Keith Meyer; Raszynski A; Totapally BR | 2017

 

  • Serial cardiac troponin concentrations as marker of cardiac toxicity in children with status asthmaticus treated with intravenous terbutaline
    Kalyanaraman M; Bhalala U; Leoncio M | 2011

 

  • Therapeutic hypercapnia enhances the inflammatory response to endotoxin in the lung of spontaneously breathing rats
    Norozian FM; Leoncio M; Torbati D; Keith Meyer; Raszynski A; Totapally BR | 2011

 

🏁 Conclusion

Driven by compassion, expertise, and a vision for innovation, Dr. Leoncio stands as a beacon in the field of pediatric medicine. His commitment to critical care continues to inspire those around him and set new standards for excellence in child health. As he looks to the future, his ongoing efforts promise to elevate pediatric intensive care—ensuring that every child, no matter how critically ill, receives the best possible chance at recovery and life.